BUMPUS NAMANDJE sold 9.2% of their position (4.39K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $15.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2026ACC: 0002060594-26-000003
Director
Since Mar 2025
-4.39K
Net shares
Net seller
$15.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.39K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−4.39K
Price / share
$3.54
Trade value
$15.53K
% of position
9.2%
6/3/2026
47.56K→43.17K
Total
Net shares
−4.39K
Net value
-$15.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/3/2026 | S · Sale | −4.39K | $3.54 | $15.53K | 9.2% | 47.56K | 43.17K |
| Total | −4.39K | -$15.53K | ||||||
Derivative Transactions0
No derivative transactions reported